CIK 0001434316
- Non-accelerated filer
- Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 651311552
- Phone
- +1 858-875-1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,525
- in 1 filing
Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-02 | RASTETTER WILLIAM H Director | Grant or award · Stock Option (Right to Buy) | +4,334 | 4,334 | ||
| 2021-06-02 | EPSTEIN ROBERT S Director | Grant or award | +2,681 | 2,681 | ||
| 2021-06-02 | EPSTEIN ROBERT S Director | Grant or award · Stock Option (Right to Buy) | +4,334 | 4,334 | ||
| 2021-06-02 | Jooss Karin Director | Grant or award | +2,681 | 2,681 | ||
| 2021-06-02 | Jooss Karin Director | Grant or award · Stock Option (Right to Buy) | +4,334 | 4,334 | ||
| 2021-06-02 | Agarwal Shefali Director | Grant or award | +2,681 | 2,681 | ||
| 2021-06-02 | Agarwal Shefali Director | Grant or award · Stock Option (Right to Buy) | +4,334 | 4,334 | ||
| 2021-06-02 | MENDLEIN JOHN Director | Grant or award | +2,681 | 159,455 | ||
| 2021-06-02 | MENDLEIN JOHN Director | Grant or award · Stock Option (Right to Buy) | +4,334 | 4,334 | ||
| 2021-05-20 | Wolchko J Scott President and CEO | Option exercise | +20,000 | $4.84 | $97K | 413,793 |
| 2021-05-20 | Wolchko J Scott President and CEO | Sale | −20,000 | $77.16 | $1.5M | 393,793 |
| 2021-05-20 | Wolchko J Scott President and CEO | Option exercise · Stock Option (right to buy) | −20,000 | 44,846 | ||
| 2021-04-23 | Wolchko J Scott President and CEO | Option exercise | +10,000 | $2.73 | $27K | 403,793 |
| 2021-04-23 | Wolchko J Scott President and CEO | Option exercise | +14,846 | $6.62 | $98K | 418,639 |
| 2021-04-23 | Wolchko J Scott President and CEO | Option exercise | +5,154 | $4.84 | $25K | 423,793 |
| 2021-04-23 | Wolchko J Scott President and CEO | Sale | −30,000 | $85.24 | $2.6M | 393,793 |
| 2021-04-23 | Wolchko J Scott President and CEO | Option exercise · Stock Option (right to buy) | −10,000 | 130,000 | ||
| 2021-04-23 | Wolchko J Scott President and CEO | Option exercise · Stock Option (right to buy) | −14,846 | 0 | ||
| 2021-04-23 | Wolchko J Scott President and CEO | Option exercise · Stock Option (right to buy) | −5,154 | 64,846 | ||
| 2021-04-22 | Wolchko J Scott President and CEO | Option exercise | +30,000 | $2.73 | $82K | 423,793 |
Page 20 of 26 · 503 trades